On December 19, 2017 Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, reported that it will be presenting at the Biotech Showcase in San Francisco, CA being held on January 8-10, 2018 (Press release, Navidea Biopharmaceuticals, DEC 19, 2017, View Source [SID1234522712]). Dr. Michael Goldberg, Chief Executive Officer of Navidea, will be giving a presentation and meeting with investors.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: Biotech Showcase
Presentation Date: Monday, January 8, 2018
Presentation Time: 10:00 am PT
Location: Hilton San Francisco Union Square, San Francisco, CA
For investors attending the Biotech Showcase, please contact Navidea Investor Relations to schedule a meeting with management at [email protected].
The presentation will be webcast live and remain available for 90 days following the presentation. To access the webcast, please visit the Investors presentations tab of the Investors section of the Navidea website at www.navidea.com.